Scarica l'app Stockscreener
152.00
0.11%
-0.0929
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products - TradingView
Retirement Systems of Alabama Sells 7,647 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Illumina price driven lower by pivotal resistanceForecast today26-01-2026 - Economies.com
Canaccord Genuity raises Illumina stock price target to $150 on solid results - Investing.com
Illumina Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Wealth Enhancement Advisory Services LLC Buys 9,997 Shares of Illumina, Inc. $ILMN - MarketBeat
iA Global Asset Management Inc. Purchases New Position in Illumina, Inc. $ILMN - MarketBeat
9,062 Shares in Illumina, Inc. $ILMN Purchased by Rakuten Investment Management Inc. - MarketBeat
Illumina Inc. (ILMN) shares see target boost as analysts see potential 2026 upside - MSN
Is It Time To Reconsider Illumina (ILMN) After Mixed Multi Year Share Performance? - Yahoo Finance
Customer Engagement Center - Illumina
Baillie Gifford & Co. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine
Whole Genome and Exome Sequencing: Global Market Review 2021-2025 and Growth Outlook 2026-2031 Featuring Illumina, Thermo Fisher Scientific, BGI Genomics and Other Leading Players - Yahoo Finance
Illumina, Inc. $ILMN Shares Sold by Teacher Retirement System of Texas - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Purchases 40,166 Shares of Illumina, Inc. $ILMN - MarketBeat
$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 - GlobeNewswire
$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance
United States Agrigenomics Market | CAGR 8% | North America Leads - openPR.com
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Illumina stock hits 52-week high at 151.35 USD By Investing.com - Investing.com Australia
Dubai Health embraces genomics to advance care and research - Illumina
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Sahm
Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest - Yahoo Finance
The Truth About Illumina Inc.: Is This Genomics Giant Still Worth Your Money? - AD HOC NEWS
Illumina (NASDAQ:ILMN) Sets New 52-Week HighHere's What Happened - MarketBeat
Illumina and Powell Gilbert in love with Lisbon - JUVE Patent
Illumina stock hits 52-week high at 151.35 USD - Investing.com
11,407 Shares in Illumina, Inc. $ILMN Acquired by Inscription Capital LLC - MarketBeat
North America Bioinformatics Market Size, Share, Trends, - openPR.com
Illumina Secures CMS Reimbursement for TruSight Oncology Test at $2,989.55 - Intellectia AI
Illumina Gets Medicare Boost for Cancer Test, Shares Climb - Benzinga
Evaluating next‑generation cloud compute for large‑scale genomic processing - Amazon Web Services (AWS)
Illumina secures CMS reimbursement for TruSight™ Oncology Compre - GuruFocus
Illumina secures CMS reimbursement for cancer genomic test at $2,989 - Investing.com
Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq
Illumina secures CMS reimbursement for cancer genomic test at $2,989 By Investing.com - Investing.com Nigeria
Press Release - Illumina
Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology - PR Newswire
Stifel raises Illumina stock price target to $155 on growth outlook - Investing.com
GRAIL Inc.Illumina's Divested Holy Grail (NASDAQ:GRAL) - Seeking Alpha
Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Finviz
The Technical Signals Behind (ILMN) That Institutions Follow - Stock Traders Daily
Illumina: What Is Next In This Sequence? (NASDAQ:ILMN) - Seeking Alpha
The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance
2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026] - 2 Minute Medicine
Is Now An Opportune Moment To Examine Illumina, Inc. (NASDAQ:ILMN)? - 富途资讯
Nordea Investment Management AB Buys 19,519 Shares of Illumina, Inc. $ILMN - MarketBeat
Oncology Research Solutions - Illumina
Stephens Investment Management Group LLC Boosts Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Acquired by ASR Vermogensbeheer N.V. - MarketBeat
Illumina, Inc.Common Stock (NQ: ILMN - FinancialContent
Genetic Disease Research Solutions - Illumina
Illumina partners with pharma giants to map disease biology at unprecedented scale - Mugglehead Magazine
2026: A turning point for precision health - Illumina
Illumina reports preliminary Q4 revenue of $1.15B - MSN
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):